Diabetes Clinical Decision Support

NARecruitingINTERVENTIONAL
Enrollment

15,732

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

January 14, 2026

Study Completion Date

May 31, 2026

Conditions
HyperglycemiaHyperglycemia StressDiabetesPreDiabetesHypoglycemia
Interventions
DEVICE

Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support

This prospective intervention will be carried out over 36 months and encompass 12 alternating GlucAlert-CDS phases lasting 3 months each. Six active phases (ON period) and six inactive phases (OFF period) will represent 18 months of intervention and control respectively. GlucAlert-CDS recognizes gaps in care denoting the automatic process of subjects' identification and inclusion. During the ON period, gap in care events detected in patients' EMR will evoke alert messages and care recommendations for clinicians in real time for their consideration. These notifications are programmed to be delivered to primary inpatient providers in direct care of these hospitalized patients. During the OFF period, the program will record the gaps in care events detected, but alerts will be inactive for providers' viewing.

Trial Locations (2)

17033

RECRUITING

Penn State Hershey Medical Center, Hershey

19605

RECRUITING

Penn State Health St. Joseph Medical Center, Reading

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Milton S. Hershey Medical Center

OTHER